Celebrating 40 Years of the Weirdest, Nerdiest Week in Movie History
Those movies are Weird Science, starring Anthony Michael Hall; Real Genius, starring Val Kilmer; and My Science Project, starring Fisher Stevens. They were released on August 2, August 7, and August 9, 1985, respectively. Which I was completely unaware of until I was looking for films to cover for milestone anniversaries and the dates jumped out at me. How the heck did not two, but three movies about nerdy people using science to do off-the-wall things all get released in the same week?
That question, unfortunately, I don't have the answer to. What I do have is history to look back on and try and dig into it. When you think of nerdy 1980s movies, the first one most of us think of is Revenge of the Nerds. Released in July 1984, the film grossed over $40 million worldwide and was largely considered a hit. We can only assume what happened next, but the fact these three movies all came out just about a year after Nerds sure seems like Hollywood was thinking, 'We need more movies with nerds as heroes.' A year later, these came out.
The first one out of the gate was Weird Science on August 2. Weird Science is the story of two outcasts (Hall and Ilan Mitchell-Smith) who hack a computer to make a virtual woman (Kelly LeBrock) with whom they can do whatever they want. This one is notable for a few reasons. It was written and directed by the legendary John Hughes, starred one of Hughes' Brat Pack members in Anthony Michael Hall, introduced the world to the model LeBrock (in one of the most widely objectifying roles of all time), and features supporting roles by the likes of Bill Paxton and Robert Downey Jr. Of the three films, it was by far the biggest hit, grossing almost $40 million worldwide despite mixed reviews (Rotten Tomatoes has it at 60%, which is literally the line between rotten and fresh). But with the biggest stars of the bunch, and Hughes at the helm, that makes sense.
A few days later, on August 7, Real Genius was released. It follows a young prodigy (Gabriel Jarret) who creates an incredible laser and is recruited by a college professor (William Atherton) to explore it further. But, we learn, the professor is actually working for the Department of Defense making weapons, so the student and his friends rebel. Most people remember two things about Real Genius. One, it stars a young Val Kilmer in an unforgettable comedic role as an eccentric college student, Chris. Two, that it ends with a house filled with popcorn while the song 'Everybody Wants to Rule the World' by Tears for Fears plays. However, despite generally positive reviews (77% on Rotten Tomatoes), it was mostly a financial disappointment, grossing less than $13 million. It did, however, find life on video and TV, where it became something of a cult classic. That's in large part due to the work of director Martha Coolidge, who previously made Valley Girl.
Two days after that, and one week after the release of Weird Science, came My Science Project. This is one most people don't remember, and maybe for good reason. It's the least directly geeky of the three, as it follows a gearhead (John Stockwell) who steals something to pass off as his science project, which turns out to be an alien device that can let him travel through space and time. It's very dumb, was hammered critically (11% on Rotten Tomatoes) and grossed just over $4 million. I had an odd fascination with the film growing up, which I wrote about here if you care to read. But, in this story, it was the third film of three, by far the worst, and took the beating it probably deserved.
Oh, it's also very crucial to remember that a little film called Back to the Future had opened in theaters about a month before any of these. It's less about 'nerds' per se but certainly centers on science, is infinitely better, and surely cannibalized some of this audience too.
So why am I writing about this? Well, because, as someone who was five years old when these films came out, by the time I was able to watch and digest movies a few years later, these were all TV mainstays. I watched Weird Science, Real Genius, and My Science Project all the time on VHS and TV. And while they all felt like they scratched a similar itch, I never in a million years would've guessed they were all released in the same week as each other. It just felt like too wild of a coincidence to not explore a bit.
The most important thing to note here, though, is that releasing movies in 1985 was incredibly different than it is today or even was a decade or two later. In 1985 there were fewer choices, fewer screens, and more time for movies to get discovered. So, there probably weren't many theaters, if any, that had all three of these movies playing at the same time. In fact, most people probably wouldn't have known about all three of them, as clearly more marketing dollars went into some over the others. More than anything, these films are a realization of a copycat nature in Hollywood that still happens today, just at a time when it was less obvious or discussed outside of the movie business. People just wanted to see movies. And people liked it if those movies were smart, funny, and starred people they related to. In 1985, we related to progress, we related to science, and we related to innovation. People who liked those things were starting to become cool again, and these movies, while maybe not directly impacting that, certainly were part of the narrative.
Do you have any memories of these films? Let us know below.
Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what's next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
8 minutes ago
- Medscape
These Two Simple Interventions May Cut CRC Recurrence Risk
This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School and Old Dominion University in Norfolk, Virginia. New guidelines have lowered the age to begin screening for colon cancer to 45 years old. Although this change is positive, we're still seeing advanced cancer in younger patients who haven't been screened in time. Once diagnosed, these patients undergo surgery and chemotherapy and often return to us asking, 'What can I do now to help myself?' Two recent studies highlight interventions that are simple, affordable, and actionable today: exercise and aspirin. Let's take a closer look at the results. Exercise's Risk Reduction Potential The idea that exercise reduces cancer recurrence and mortality is supported by observational data. The mechanistic effects behind this have been ascribed to metabolic growth factors, inflammatory changes, immune function changes, and perhaps even positive impact on sleep. A study just published in The New England Journal of Medicine examined structured exercise after adjuvant chemotherapy for colon cancer. The phase 3 randomized CHALLENGE trial, mostly conducted at Canadian and Australian centers, recruited patients with resected stage II or III colon cancer (9.8% and 90.2%, respectively) who had completed adjuvant chemotherapy. Patients with recurrences within a year of diagnosis were excluded, as they were more likely to have highly aggressive, biologically active disease. Patients were randomized to receive healthcare education materials alone or in conjunction with a structured exercise program over a 3-year follow-up period. The exercise intervention, delivered in person or virtually, focused on increasing recreational aerobic activity over baseline by at least 10 metabolic equivalent task (MET). An increment of 10 MET hours per week is not too vigorous. It is essentially the equivalent of adding about 45-60 minutes of brisk walking or 25-30 minutes of jogging 3-4 times a week. Patients were asked to increase MET over the first 6 months and then maintain or further increase the amount over the next 2.5 years. They were permitted to structure their own exercise program by choosing the type, frequency, intensity, and duration of aerobic exercise. The primary endpoint was disease-free survival, with secondary endpoints assessing overall survival, patient-reported outcomes, and other outcomes. Although designed to detect differences at 3 years, follow-up was also performed out to 5 and 8 years. At a median follow-up of 7.9 years, exercise reduced the relative risk of disease recurrence, new primary cancer, or death by 28% ( P =.02). This benefit persisted — and even strengthened — over time, with disease-free survival increasing by 6.4 and 7.1 percentage points at 5 and 8 years, respectively. Musculoskeletal adverse events were slightly higher in the exercise group compared with the health education group (18.5% vs 11.5%, respectively), but only 10% were directly attributed to the exercise. There are considerations when interpreting these results. First, there was an attrition over time for compliance and training. It would be interesting to see whether that impacted the results. Second, it's unclear whether patient pedigree or a genomic pathway may predispose to a benefit here for the exercise group. But overall, this phase 3 trial provides class 1 evidence supporting exercise as a low-cost, high-impact intervention to reduce cancer recurrence. Adjuvant Aspirin in Colon Cancer Subset That's a perfect segue into another recent study looking at the effects of adjuvant aspirin on the prevention of recurrence. The ALASCCA trial— conducted across centers in Sweden, Denmark, Finland, and Norway — assessed patients with stage I-III rectal cancer or stage II-III colon cancer. It focused on a subset of patients with an oncogenic abnormality called PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha). PIK3CA occurs in approximately a third of colon cancers and is associated with significant chemotherapy resistance and a higher rate of disease progression. Of the included patients, 1103 (37%) had alterations in the PIK3CA pathway. Researchers randomized patients to receive either 160 mg of aspirin or placebo daily for 3 years, starting within 3 months of surgery. Among patients with PIK3CA mutations, aspirin dramatically reduced the risk for time to recurrence by nearly 50% at 3 years ( P =.044). Adverse events associated with aspirin were minimal, including one case each of gastrointestinal bleeding, hematoma, and allergic reaction. There is no evidence that higher aspirin doses provide greater prevention of colorectal cancer recurrence. The 160 mg use in the current study is fairly normal, roughly equivalent to two low-dose (81 mg) aspirin tablets. Now, it's worth noting that the use of aspirin for the primary prevention of cardiovascular disease was initially recommended by the US Preventive Task Services Force in 2016. This recommendation was then recanted in 2022, when the same group reported limited net benefit to this approach. Two Proactive Actions These studies highlight two interventions — exercise and aspirin — that are low cost, accessible, and appeal to patients eager to help prevent their cancer from recurring. Exercise is broadly beneficial and can be recommended immediately. For aspirin, patients should work with their oncologist to determine their PIK3CA mutation status, as this subgroup appears to benefit the most. These findings offer patients meaningful, proactive interventions they can apply to support their recovery and reduce the risk of recurrence. Hopefully these new findings will help guide your clinical conversations. I'm Dr David Johnson. Thanks for listening.
CNN
9 minutes ago
- CNN
Flaco Jimenez, Texas accordionist who expanded popularity of conjunto and Tejano music, dies at 86
Flaco Jimenez, the legendary accordionist from San Antonio who won multiple Grammys and helped expand the popularity of conjunto, Tejano and Tex-Mex music, died Thursday. He was 86. Jimenez's death was announced Thursday evening by his family on social media. 'It is with great sadness that we share tonight the loss of our father, Flaco Jimenez. He was surrounded by his loved ones and will be missed immensely. Thank you to all of his fans and friends—those who cherished his music. And a big thank you for all of the memories. His legacy will live on through his music and all of his fans,' Jimenez's family said in a statement. His family did not disclose a cause of death. Jimenez's family had announced in January that he had been hospitalized and had been 'facing a medical hurdle.' His family did not provide any other information on his medical condition at the time. Born Leonardo Jimenez in 1939, he was known to his fans by his nickname of Flaco, which means skinny in Spanish. He was the son of conjunto pioneer Santiago Jimenez. Conjunto is a musical genre that originated in South Texas and blends different genres and cultural influences. According to the Butler School of Music at the University of Texas at Austin, the development of conjunto 'began more than a century ago when Texans of Mexican heritage (Tejanos) took an interest in the accordion music of German, Polish, and Czech immigrants. The ensuing Tejano accordion music, accompanied by the bajo sexto (replacing the European tuba) soon came to represent the Tejano way of life, which was closely associated with working in the agricultural fields. The music remains unchanged and serves as a symbol that binds many Tejano communities in South and Central Texas.' Jimenez refined his conjunto musical skills by playing in San Antonio saloons and dance halls. He began performing in the 1960s with fellow San Antonio native Douglas Sahm, the founding member of the Sir Douglas Quintet. Jimenez also played with Bob Dylan, Dr. John and Ry Cooder. Throughout his career, Jimenez added other influences into conjunto music, including from country, rock and jazz. In the 1990s, Jimenez was part of the Tejano supergroup the Texas Tornados, which included Sahm, Augie Meyers and Freddy Fender. The group won a Grammy in 1991 for the song, 'Soy de San Luis.' Jimenez also won another Grammy in 1999 as part of another supergroup, Los Super Seven. Jimenez earned five Grammys and was awarded a Grammy Lifetime Achievement Award in 2015. He was also inducted into the National Hispanic Hall of Fame and NYC International Latin Music Hall of Fame and was named a Texas State Musician in 2014. When Jimenez was named a 2022 National Medal of Arts recipient, the White House said he was being honored for 'harnessing heritage to enrich American music' and that by 'blending Norteño, Tex Mex, and Tejano music with the Blues, Rock n' Roll, and Pop Music, he sings the soul of America's Southwest.' 'Flaco, your legacy will forever be remembered with fond memories. We appreciate the gift of your musical talent, which brought joy to countless fans. Your passing leaves a void in our hearts,' the Texas Conjunto Music Hall of Fame and Museum said in a post on social media. Kyle Young, the CEO of the Country Music Hall of Fame and Museum in Nashville, Tennessee, said Jimenez 'was a paragon of Tejano conjunto music.' 'Whether he was recording with Bob Dylan, Linda Ronstadt or the Rolling Stones, or working with his own supergroup, the Texas Tornados, Flaco drew millions of listeners into a rich musical world they might not have discovered on their own,' Young said.
Associated Press
9 minutes ago
- Associated Press
American Eagle responds to critics over ad with Sydney Sweeney, saying it was always about the jeans
NEW YORK (AP) — Teen retailer American Eagle Outfitters has a message to its critics, who took issue over its denim ad campaign with 27-year-old actor Sydney Sweeney that sparked a debate over race and Western beauty standards. The campaign, the retailer said, was always about the jeans. In a statement posted on American Eagle's Instagram account on Friday, the retailer said the ad campaign 'is and always was about the jeans. Her jeans. Her story. We'll continue to celebrate how everyone wears their AE jeans with confidence, their way. Great jeans look good on everyone.' The message marked the first time the teen retailer responded to days of backlash since the ad with the tagline 'Sydney Sweeney has great jeans' launched last week. In the run-up to the ad blitz, the company's chief marketing officer told trade media outlets that it included 'clever, even provocative language' and was 'definitely going to push buttons.' It's unclear if the company knew how much controversy the ad could raise. Most of the negative reception focused on videos that used the word 'genes' instead of 'jeans' when discussing the blonde-haired, blue-eyed actor known for the HBO series 'Euphoria' and 'White Lotus.' Critics found the most troubling was a teaser video in which Sweeney says, 'Genes are passed down from parents to offspring, often determining traits like hair color, personality and even eye color. My jeans are blue.' The video appeared on American Eagle's Facebook page and other social media channels but is not part of the ad campaign. Some critics saw the wordplay as a nod, either unintentional or deliberate, to eugenics, a discredited theory that held humanity could be improved through selective breeding for certain traits. Other commenters accused detractors of reading too much into the campaign's message. Some marketing experts said the buzz is always good even if it's not uniformly positive. 'If you try to follow all the rules, you'll make lots of people happy, but you'll fail,' Allen Adamson, co-founder of marketing consultancy Metaforce said. 'The rocket won't take off.'
